Max-40279

News alerts, weekly reports and conference planners

Company:

Maxinovel

Drug class:

PDGFR inhibitor, FLT3 inhibitor, FGFR1 inhibitor, FGFR2 inhibitor, JAK inhibitor, HPK1 inhibitor

FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D
FLT3 D835Y	Acute Myelogenous Leukemia	FLT3 D835Y	Acute Myelogenous Leukemia	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D

Associations
(2)